COMBINATION CHEMOTHERAPY WITH BEVACIZUMAB, DOCETAXEL AND CARBOPLATIN FOR CHEMOTHERAPY-NAIVE PATIENTS WITH NON-SQUAMOUS CELL LUNG CARCINOMA: PHASE II STUDY.

被引：0
|
作者：
Matsumoto, Masaru [1 ]
Takiguchi, Yuichi [2 ]
Minato, Kouichi [3 ]
Yoshimori, Kozo [4 ]
Okamoto, Hiroaki [5 ]
Kuribayashi, Hidehiko [6 ]
Ando, Masahiro [7 ]
Shingyoji, Masato [8 ]
Noro, Rintaro [9 ]
Gemma, Akihiko [9 ]
机构：
[1] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo, Japan
[2] Chiba Univ Hosp, Chiba, Japan
[3] Gunma Prefectural Canc Ctr, Ota, Japan
[4] Fukujuji Hosp, AntiTB Assoc, Tokyo, Japan
[5] Yokohama Municipal Citizens Hosp, Dept Resp Med & Med Oncol, Yokohama, Kanagawa, Japan
[6] Chiba Hokusoh Hosp, Nippon Med Sch, Chiba, Japan
[7] Tsuboi Canc Ctr, Fukushima, Japan
[8] Chiba Canc Ctr, Dept Thorac Dis, Chiba, Japan
[9] Nippon Med Sch, Dept Pulm Med & Oncol, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
non-squamous non-small cell lung cancer; Bevacizumab; first line chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.10-045
引用
收藏
页码：S1177 / S1178
页数：2
相关论文
共 50 条
  • [21] A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer
    Kasahara, Kazuo
    Kimura, Hideharu
    Shibata, Kazuhiko
    Araya, Tomoyuki
    Sone, Takashi
    Oribe, Yoshitaka
    Furusho, Shiho
    Kita, Toshiyuki
    Shirasaki, Hiroki
    Oribe, Yoshitaka
    Yoshimi, Yuzo
    Ueda, Akihito
    Tachibana, Hideki
    Shintani, Hiromoto
    Mizuguchi, Masayuki
    Nishi, Kohichi
    Fujimura, Masaki
    Nakao, Shinji
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3723 - 3728
  • [22] Phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer
    Kim, B.
    Kim, H.
    Kim, T.
    Lee, H.
    Lee, B.
    Kim, J.
    Nam, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer
    Kim, Hye Jin
    Kim, Tae Gyoon
    Park, Won Hyoung
    Song, Dae Geun
    Min, Bo Young
    Park, Hyoun Kyoung
    Lee, Hyun Jung
    Nam, Seung-Hyun
    Kim, Bong-Seog
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S689 - S689
  • [24] A phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer
    Kim, Hye Jin
    Kim, Tae Gyoon
    Lee, Hyun Jeong
    Kim, Jee Ho
    Lim, Byung Hoon
    Seo, Jae Won
    Kang, Eun Mi
    Lee, Byung Uk
    Ahn, Young Mi
    Roh, Yong Ho
    Nam, Seung-Hyun
    Kim, Bong-Seog
    LUNG CANCER, 2010, 68 (02) : 248 - 252
  • [25] Phase lb extension study of eribulin in combination with carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer (NSCLC)
    Raftopoulos, H.
    Aisner, J.
    Kumar, K.
    Goel, S.
    Dittrich, C.
    Jain, M.
    Gopalakrishna, P.
    Salazar, P.
    Jones, B.
    Petrylak, D.
    ONKOLOGIE, 2013, 36 : 29 - 29
  • [26] PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH CARBOPLATIN PLUS PACLITAXEL AS FIRST-LINE CHEMOTHERAPY FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION
    Tamiya, Akihiro
    Tamiya, Motohiro
    Yamadori, Tadahiro
    Yasue, Tomomi
    Nakao, Keiko
    Shiroyama, Takayuki
    Asami, Kazuhiro
    Morishita, Naoko
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Hirashima, Tomonori
    Atagi, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1159 - S1160
  • [27] Phase II study of bevacizumab in combination with carboplatin plus paclitaxel as first-line chemotherapy for non-squamous non-small cell lung cancer with malignant pleural effusion
    Tamiya, M.
    Tamiya, A.
    Asami, K.
    Okishio, K.
    Kawagchi, T.
    Suzuki, H.
    Okamoto, N.
    Kawase, I.
    Atagi, S.
    Hirashima, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S826 - S826
  • [28] A Phase Ib study of bavituximab plus carboplatin and pemetrexed in chemotherapy-naive incurable stage IIIb/IV non-squamous non-small cell lung cancer.
    Grilley-Olson, Juneko E.
    Villaruz, Liza C.
    Stinchcombe, Thomas E.
    Weiss, Jared
    Shan, Joseph
    Vashishtha, Anshu
    Ivanova, Anastasia
    Socinski, Mark A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [29] Phase II study of docetaxel plus enoxaparin in chemotherapy-naive patients with metastatic non-small cell lung cancer: preliminary results
    Robert, F
    Busby, E
    Marques, MB
    Reynolds, RE
    Carey, DE
    LUNG CANCER, 2003, 42 (02) : 237 - 245
  • [30] Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Karvounis, N
    Batzios, S
    Athanassiou, A
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3816 - 3821
12345